Remove Bioinformatics Remove Molecular Biology Remove Science
article thumbnail

What single cells are revealing about brain disorders

Drug Target Review

From maths and physics to molecular biology Schnall-Levin did not begin in the life sciences. “I I started looking around and getting interested in biology. I got my eyes opened to molecular biology, bioinformatics, computational biology and these emerging fields at the time.”

article thumbnail

Solving the disconnect between lab and data scientists: part 1

Drug Target Review

In the rapidly evolving landscape of life sciences, the communication gap between laboratory scientists and data scientists remains a significant challenge. Ian Kerman (IK): My name is Ian Kerman and I’m currently a data science and AI solutions architect at Certara. RS: You co-lead a working group at SLAS.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Solving the disconnect between lab and data scientists: part 2

Drug Target Review

In the rapidly evolving landscape of life sciences, the communication gap between laboratory scientists and data scientists remains a significant challenge. I understand what happens in the lab, which helps on the data science side because I can better appreciate the work that goes into collecting the data.

article thumbnail

What Makes a Mature Science

Codon

The alchemy of van Helmont’s day was not a mature science. At some point between the 17th and 18th centuries, the study of matter and substance went from being an immature science, a bunch of people hanging around and wearing funny hats, to a mature one, a bunch of scientists hanging around and wearing funny hats.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Rising from Research Scientist to Senior Scientist, I supported early-stage DD efforts within their Protein Science group, based in Cambridge, UK.

article thumbnail

Leveraging ADCs in precision oncology strategy

Drug Target Review

Caris Life Sciences® (Caris) has been at the forefront of precision medicine. Caris Discovery, the therapeutic research arm of Caris Life Sciences, was launched to address the paucity of novel oncology drug targets and is uniquely poised to discover first-in-class ADC targets.

article thumbnail

Code breaking and the Human Genome Project

The Open Targets Blog

However, there are notable parallels both in the way the science was conducted and, at least for the genome project in the UK, the particular physical settings and sensibilities. Bioinformatics, Volume 13, Issue 4, August 1997, Pages 333–344 9. Now I don’t want to claim too much. Left: Bletchley Park, photo by Einar H.

DNA